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Volume 51, Number 11S Abstracts 29SResults: Over a 7-year period, 126 patients were fol-
lowed. Serial CTA was performed in 59 controls, while 67
patients were followed with the NCT protocol. Mean
follow-up was 2.07 years. There were no differences in Age,
Gender, or Initial Aneurysm Volume or Size. There were
35 total Endoleaks identified. Twenty of these were early
(30days post EVAR) Endoleaks. The remaining 15 leaks
were late in nature, 10 in the contrast group and 5 in the
noncontrast group, p  0.17. NCT aneurysm sac volume
changes prompted contrasted studies in all 5 late leaks.
Mean volume change was 11.2 cm3, an average change of
5.88%. These findings were not significantly different than
the late leaks found by routine contrast studies, 8.9cm3
(4.98%, p  0.58). There were no delayed ruptures or
emergent reinterventions in the NCT group.
Conclusions: After EVAR, serial volumetric analysis
with noncontrast enhanced Computed Tomography ap-
pears to be a safe and effective follow-up imaging modality.
It requires the involvement of dedicated cardiovascular
radiologists. Further, long-term and larger investigation is
needed to confirm the safety and efficacy of this follow-up
protocol.
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Objectives: Unlike atherosclerotic peripheral vascular
disease, comorbid abdominal aortic aneurysm (AAA) has
not been studied in terms of its effects on outcomes after
coronary artery bypass grafting (CABG). We aimed to
determine whether having comorbid AAA affected the
in-hospital outcomes of patients who had undergone iso-
lated CABG surgery.
Methods: Using Nationwide Inpatient Sample data
from 1998-2007, we identified 2, 607, 522 patients who
underwent isolated CABG, of whom 32, 957 had comor-
bid AAA. Hierarchic multivariable regression models were
used to analyze the independent effect of AAA on out-
comes. Primary end points were in-hospital mortality and
morbidity. Secondary end points were hospital length of
stay and charges.Results: Patients who had concomitant AAA were
older (71 8 vs 65 11 years; p 0.001) and had higher
Deyo comorbidity scores (4.7  1.4 vs 3.0  1.7; p 
0.001) than patients without AAA. Unadjusted in-hospital
mortality was similar for both groups (2.4% for patients
with AAA vs 2.5% without AAA; p  0.27). After risk-
adjustment, AAA did not affect mortality (OR  1.0; p 
0.6). Patients with AAA had a 20% higher likelihood of
overall post-CABG morbidity (odds ratio [OR]  1.21;
p  0.001). The length of stay was slightly longer for
patients with AAA by 0.15 days (p  0.01), and hospital
charges were higher by $1291 (p  0.01). Subgroup anal-
ysis revealed that patients with AAA were more likely to
have cardiac (OR  1.2; p  0.001) and neurologic com-
plications (OR  1.2; p  0.005) after CABG.
Conclusions: AAA independently predicted higher
overall morbidity, specifically cardiac and neurologic
complications, in patients who underwent CABG. In-
hospital mortality was not affected, although in-hospital
length of stay and charges were higher in patients with
AAA. Because the presence of AAA appears to have an
important independent influence on postoperative
CABG outcomes, further studies are required to deter-
mine whether AAA should be incorporated into CABG
risk-assessment models.
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Objectives: Studies have documented a slight but sig-
nificant deterioration of renal function after endovascular
repair of AAA (EVAR). We investigated whether medica-
tion with statins may prevent perioperative renal deteriora-
tion.
Methods: In 127 patients receiving EVAR the med-
ication was reliably retrievable. Patients were divided
according to whether their medication included statins
( 3 months). Secondly, they were subdivided according
to their supra- or infra-renal endograft fixation. Serum
creatinine and creatinine clearance were determined pre-
operatively at six and twelve months. Patients with
known preexisting renal disease, with incorrect place-
ment of the stent-graft resulting in severe renal artery
stenosis, and with occlusion or renal parenchymal infarc-
tion were excluded from the study.
Results: Patients receiving an infrarenal fixation of
their graft had no change in the renal function, regardless
